- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 12, 2026
59026439ASSDCHPFSabourad Dextrose with Chloramphenicol and Cycloheximide LAB-AGAR™ is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class A. Manufactured by BioMaxima Spółka Akcyjna. Placed on the EU market in Poland. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
05902643948631BT 5025.01(01)05902643948631
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0104010306CULTURE MEDIA IN BOTTLESPL-MF-000039473The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
Primary placement in Poland; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| PolandPrimary placement | — | Still on market |
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →59026439ASRPMIS4On the marketRPMI MOPS LAB-AGAR™59026439ASRPMIS4On the marketRPMI MOPS LAB-AGAR™59026439ASRPMIS4On the marketSabourad Dextrose with Chloramphenicol and Cycloheximide LAB-AGAR™59026439ASSDCHPFOn the marketSabourad Dextrose with Chloramphenicol and Cycloheximide LAB-AGAR™59026439ASSDCHPFOn the marketSABOURAUD + CHLORAMPHENICOL LAB-AGAR™/ SABOURAUD + CHLORAMPHENICOL + ACTIDIONE LAB-AGAR™59026439A0DP297YOn the marketNo certificate specifically references this device's Basic UDI-DI.
No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.